Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Scaffolds: A Biomaterial Engineering in Targeted Drug Delivery for Osteoporosis Publisher Pubmed



Poorirani S1 ; Taheri S1 ; Mostafavi SA1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences and Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, 8174673461, Iran

Source: Osteoporosis International Published:2023


Abstract

Osteoporosis is an increasingly common condition that causes low bone density, porous bone, and increased fracture risk. Treatments for osteoporosis are divided into two categories: (a) antiresorptive and (b) anabolic. To decrease side effects of drug and dosage level variations caused by several consecutive administrations, various drug delivery systems have been proposed. Among them, scaffolds are one of the drug delivery systems that led to drug impart with high loading and suitable efficiency to specific sites which retain active agents at acceptable therapeutic levels. The purpose of this review was to explain the role of scaffolds in targeted drug delivery to bone tissue for the treatment of osteoporosis. © 2022, International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.
Experts (# of related papers)
Other Related Docs
35. Pepgen-P15 Delivery to Bone: A Novel 3D Printed Scaffold for Enhanced Bone Regeneration, Journal of Drug Delivery Science and Technology (2024)
36. Pcl-Forsterite Nanocomposite Fibrous Membranes for Controlled Release of Dexamethasone, Journal of Materials Science: Materials in Medicine (2015)